Bristol-Myers Squibb Co. Earnings Dividend

Bristol-Myers Squibb Co.’s revenue jumped 2.57% since last year same period to $11489Mn in the Q1 2026. On a quarterly growth basis, Bristol-Myers Squibb Co. has generated -8.1% fall in its revenue since last 3-months.

Bristol-Myers Squibb Co.’s net profit jumped 9.04% since last year same period to $2678Mn in the Q1 2026. On a quarterly growth basis, Bristol-Myers Squibb Co. has generated 146.59% jump in its net profits since last 3-months.

Bristol-Myers Squibb Co.’s net profit margin jumped 6.31% since last year same period to 23.31% in the Q1 2026. On a quarterly growth basis, Bristol-Myers Squibb Co. has generated 168.34% jump in its net profit margins since last 3-months.

Bristol-Myers Squibb Co.’s price-to-earnings ratio after this Q1 2026 earnings stands at 15.82.

Bristol-Myers Squibb Co.’s earning per share (EPS) estimates for the current quarter stand at 1.61 - a 40% jump from last quarter’s estimates.

Bristol-Myers Squibb Co.’s earning per share (EPS) estimates for the current year stand at 1.61.

Bristol-Myers Squibb Co.’s earning per share (EPS) fell -27.22% since last year same period to 1.31 in the Q1 2026. This indicates that the Bristol-Myers Squibb Co. has generated -27.22% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bristol-Myers Squibb Co.’s return on assets (ROA) stands at 0.11.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bristol-Myers Squibb Co.’s return on equity (ROE) stands at 0.39.

Bristol-Myers Squibb Co. declared 0.63 dividend per share during the earnings announcement for Q1 2026.